%0 Case Reports
%T Renal Medullary Carcinoma: The Zebra Amongst the Horses.
%A Dalela D
%A Batie S
%A Carolan A
%A Schlomer B
%A Collins R
%A Jacobs M
%J Urology
%V 187
%N 0
%D 2024 May 10
%M 38467288
%F 2.633
%R 10.1016/j.urology.2024.02.048
%X A 13-year old Latino male presented with recurrent gross hematuria, 5cm right-sided poorly defined heterogeneous mass, enlarged retrocaval lymph nodes, and 1.2 cm paratracheal lymph node. Given the need for multiple blood transfusions, robot-assisted radical nephrectomy with lymph node dissection was performed. Pathology revealed pT3a high-grade tumor, clear margins, and positive lymph node. Additionally, with multiple sickled RBCs and loss of staining of SMARCB1 in tumor specimen, and hemoglobin electrophoresis suggesting sickle cell trait, diagnosis of metastatic renal medullary carcinoma was confirmed. The patient was enrolled into COG AREN 03B2 trial, and has completed 10 cycles of carboplatin/gemcitabine/bortezomib alternating with cisplatin/gemcitabine/paclitaxel, with no evidence of recurrent disease 9 months post-surgery.